PATENT CLAIM ANALYSIS

Application Number: 15886659
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "468000"]

Abstract:
Opioid controlled release formulation resistant to alcohol extraction of the opioid.

Claim (Index 62):
The dosage form of any of  claims 37  to  60 , wherein the opioid salt is oxycodone hydrochloride and the dosage form comprises:\n 5 mg oxycodone hydrochloride, \n 10 mg oxycodone hydrochloride, \n 15 mg oxycodone hydrochloride \n 20 mg oxycodone hydrochloride, \n 30 mg oxycodone hydrochloride, \n 40 mg oxycodone hydrochloride, \n 45 mg oxycodone hydrochloride \n 60 mg oxycodone hydrochloride, \n 80 mg oxycodone hydrochloride, \n 90 mg oxycodone hydrochloride \n 120 mg oxycodone hydrochloride or \n 160 mg oxycodone hydrochloride

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13900873', '13333560', '13901218', '14040535', '15245338']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7072391340025083
- 35 USC 102 Novelty (BERT): 0.5518729181388629
- Combined Prediction Score: 0.6917025124161437
- Mean Citation Score: 395.594268
- Max Citation Score: 406.89218
- Similarity Product: 292.38577415822624

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test